17 Apr 2009
ABBOTT GMBH & CO KG AND ANOTHER v. PHARMAREG CONSULTING CO LTD AND ANOTHER
- Citation
- ABBOTT GMBH & CO KG AND ANOTHER v. PHARMAREG CONSULTING CO LTD AND ANOTHER
- Court
- Court of First Instance
- Case number
- HCA166/2009
Court granted the interlocutory injunction because plaintiffs demonstrated very good prospects of success on both validity (Swiss‑type second medical use for obesity valid) and infringement (OBIRAX produced by Micro using Sibutramine and imported, stocked and put on market by defendants falls within s73(1)(c)), damages were an inadequate remedy given defendants' limited capital and risk of a commercial bridgehead before patent expiry, and any delay did not make grant unjust.